BCC 2023 | Long-term evidence for partial breast irradiation in early breast cancer

Icro Meattini, MD, University of Florence, Florence, Italy, outlines accumulating long-term evidence for partial breast irradiation, highlighting long-term results of a multicentre, Phase III trial investigating accelerated partial breast irradiation (APBI) using multicatheter brachytherapy for patients aged 40 years or older with early breast cancer. This interview took place at the St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.